Apr 7, 2016 by Brian Orelli, PhDWhy Ionis Pharmaceuticals Inc Couldn't Hold Its Price TodayAn FDA clinical hold, oh my.
Apr 7, 2016 by Brian Orelli, PhDCelldex Therapeutics, Inc. Can Thank Pfizer and Allergan for Its Wednesday BounceIt's a biotech thing.
Apr 6, 2016 by Brian Orelli, PhDWhy Valeant Pharmaceuticals Intl. Inc. Shot Up TodayA new CEO is imminent.
Apr 4, 2016 by Brian Orelli, PhDCelldex Therapeutics, Inc. Sure Loves MondaysThe biotech continues its climb off its post-clinical-trial-fail lows.
Apr 4, 2016 by Brian Orelli, PhDWhy Natus Medical Inc. Reported Lower TodayPreliminary first-quarter revenue at the medical-device maker was lower than previous guidance.
Mar 29, 2016 by Brian Orelli, PhDWhy Keryx Biopharmaceuticals Ironed Out a Higher Stock PricePositive phase 3 data should help increase the market for Auryxia.
Mar 28, 2016 by Brian Orelli, PhD9 Things You Need to Know About Biosimilar DrugsDon't invest in the space until you know these things.
Mar 24, 2016 by Brian Orelli, PhDWhy Lannett Company, Inc. Guided Lower TodayManagement lowers guidance, and the company receives an analyst downgrade to boot.
Mar 21, 2016 by Brian Orelli, PhDCelldex Therapeutics, Inc. Bounces HigherInvestors finally decide it's fallen far enough.
Mar 21, 2016 by Brian Orelli, PhDHow Valeant Pharmaceuticals Intl. Inc. Resigned Itself to a Higher Stock PriceA shakeup at the top.
Mar 15, 2016 by Brian Orelli, PhDExelixis, Inc.'s EKG-Like Stock Chart Hits a Low SpotInvestors can't figure out how to value the biotech ahead of the FDA approval of cabozantinib.
Mar 8, 2016 by Brian Orelli, PhDWhy bluebird bio Inc Presented a Lower Price TodayIt appears the biotech is experiencing the old sell-the-news decline.
Mar 7, 2016 by Brian Orelli, PhDExelixis, Inc. Partnering Before ApprovalIn conjunction with earnings, the biotech announced a deal to out-license some rights to cabozantinib.
Mar 6, 2016 by Brian Orelli, PhDEmergent BioSolutions Inc. Expanding AlongThe biodefense specialist posts solid fourth-quarter earnings, but there's potential for better results with expanding manufacturing and additional products.
Mar 2, 2016 by Brian Orelli, PhDWaiting on Celldex Therapeutics, Inc.Earnings get the second fiddle with data expected any day now.
Mar 2, 2016 by Brian Orelli, PhDBioMarin Pharmaceutical Inc. Ratchets Up the Profitability TalkInvestors will have to wait until next year, though.
Mar 1, 2016 by Brian Orelli, PhDWhy Celldex Therapeutics, Inc. and bluebird bio, Inc. Jumped TodayA little momentum with an analyst buy rating thrown in for good measure propels the biotechs.
Mar 1, 2016 by Brian Orelli, PhDIonis Pharmaceuticals Inc: New Name, Same Waiting GameAt least there was a mention of profitability during the biotech's conference call.
Feb 29, 2016 by Brian Orelli, PhDWhy Celldex Therapeutics and Momenta Pharmaceuticals Traded Down TodayIt's a biotech thing.
Feb 29, 2016 by Brian Orelli, PhDbluebird bio Inc.: Waiting for ASHThe biotech releases earnings, but the focus is on the American Society of Hematology meeting in November.
![Russell_Watt-008[1]](https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F201463%2Frussell_watt-0081.jpg&w=384&op=resize)
![celldexheader-sourcecelldextherapeuticsinc_large[1]](https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F201396%2Fcelldexheader-sourcecelldextherapeuticsinc_large1.jpg&w=384&op=resize)
![Bill%20Akman-029-final[1]](https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F201347%2Fbill20akman-029-final1.jpg&w=384&op=resize)
![Pipeline-Chart-_01[1]](https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F200948%2Fpipeline-chart-_011.png&w=384&op=resize)
![natusnewbornscreening_large1_large1_large1_large[1]](https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F200902%2Fnatusnewbornscreening_large1_large1_large1_large1.png&w=384&op=resize)
![640px-Iron_deficiency_anemia_blood_film[1]](https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F200402%2F640px-iron_deficiency_anemia_blood_film1.jpg&w=384&op=resize)
![7035932329_b91d092854_z_d[1]](https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F200103%2F7035932329_b91d092854_z_d1.jpg&w=384&op=resize)
![Hirnmetastase_MRT-T1_KM[1]](https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F199700%2Fhirnmetastase_mrt-t1_km1.jpg&w=384&op=resize)
![mikepearson[1]](https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F199672%2Fmikepearson1.jpg&w=384&op=resize)
![rarechart1[1]](https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F198469%2Frarechart11.jpg&w=384&op=resize)
![10805488746_9df92b6c35_o_d[1]](https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F197656%2F10805488746_9df92b6c35_o_d1.jpg&w=384&op=resize)